Report cover image

Anxiolytics Market by Type (Antidepressants, Antihistamines, Azapirones), Form (Capsules, Tablets), Route of Administration, Indication, Distribution Channel - Global Forecast 2024-2030

Publisher 360iResearch
Published Jan 15, 2024
Length 181 Pages
SKU # IRE18418432

Description

Anxiolytics Market by Type (Antidepressants, Antihistamines, Azapirones), Form (Capsules, Tablets), Route of Administration, Indication, Distribution Channel - Global Forecast 2024-2030


The Anxiolytics Market size was estimated at USD 1.24 billion in 2023 and expected to reach USD 1.32 billion in 2024, at a CAGR 7.27% to reach USD 2.03 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anxiolytics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anxiolytics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anxiolytics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accord Healthcare US, Akorn Operating Company LLC, Alvogen, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca PLC, Bausch Health Companies Inc., Dellwich Healthcare LLP, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, H. Lundbeck A/S, Hameln Pharma GmbH, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Lifecare Neuro Products Limited, Lifegenix, Neurocon Inc., Noreva Biotech, Novartis AG, Pfizer Inc., Sanofi S.A., and Sun Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Anxiolytics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

Antidepressants
  • Antihistamines
  • Azapirones
  • Benzodiazepines
  • Beta-blockers
  • Nonbenzodiazepines
  • Sedative-hypnotics
  • Form

    Capsules
  • Tablets
  • Route of Administration

    Oral
  • Parenteral
  • Indication

    Generalized Anxiety Disorder
  • Panic Disorder
  • Phobias
  • Posttraumatic Stress Disorder (PTSD)
  • Distribution Channel

    Offline
  • Online
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Anxiolytics Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anxiolytics Market?
    3. What are the technology trends and regulatory frameworks in the Anxiolytics Market?
    4. What is the market share of the leading vendors in the Anxiolytics Market?
    5. Which modes and strategic moves are suitable for entering the Anxiolytics Market?


    Note: PDF & Excel + Online Access - 1 Year

    • Table of Contents

    181 Pages
    1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Anxiolytics Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Increasing prevalence of anxiety disorders among people and awareness about mental health and treatment
    5.1.1.2. Emergence of anxiolytics as sedative agents in anesthesia
    5.1.2. Restraints
    5.1.2.1. Problems associated with side effects after prolonged use of anxiolytics
    5.1.3. Opportunities
    5.1.3.1. Technical advancement of anxiolytic drugs in pharmaceutical sector
    5.1.3.2. Increasing government initiatives to promote mental health and wellbeing
    5.1.4. Challenges
    5.1.4.1. Problems related to social-stigma associated with mental disorders
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Anxiolytics Market, by Type
    6.1. Introduction
    6.2. Antidepressants
    6.3. Antihistamines
    6.4. Azapirones
    6.5. Benzodiazepines
    6.6. Beta-blockers
    6.7. Nonbenzodiazepines
    6.8. Sedative-hypnotics
    7. Anxiolytics Market, by Form
    7.1. Introduction
    7.2. Capsules
    7.3. Tablets
    8. Anxiolytics Market, by Route of Administration
    8.1. Introduction
    8.2. Oral
    8.3. Parenteral
    9. Anxiolytics Market, by Indication
    9.1. Introduction
    9.2. Generalized Anxiety Disorder
    9.3. Panic Disorder
    9.4. Phobias
    9.5. Posttraumatic Stress Disorder (PTSD)
    10. Anxiolytics Market, by Distribution Channel
    10.1. Introduction
    10.2. Offline
    10.3. Online
    11. Americas Anxiolytics Market
    11.1. Introduction
    11.2. Argentina
    11.3. Brazil
    11.4. Canada
    11.5. Mexico
    11.6. United States
    12. Asia-Pacific Anxiolytics Market
    12.1. Introduction
    12.2. Australia
    12.3. China
    12.4. India
    12.5. Indonesia
    12.6. Japan
    12.7. Malaysia
    12.8. Philippines
    12.9. Singapore
    12.10. South Korea
    12.11. Taiwan
    12.12. Thailand
    12.13. Vietnam
    13. Europe, Middle East & Africa Anxiolytics Market
    13.1. Introduction
    13.2. Denmark
    13.3. Egypt
    13.4. Finland
    13.5. France
    13.6. Germany
    13.7. Israel
    13.8. Italy
    13.9. Netherlands
    13.10. Nigeria
    13.11. Norway
    13.12. Poland
    13.13. Qatar
    13.14. Russia
    13.15. Saudi Arabia
    13.16. South Africa
    13.17. Spain
    13.18. Sweden
    13.19. Switzerland
    13.20. Turkey
    13.21. United Arab Emirates
    13.22. United Kingdom
    14. Competitive Landscape
    14.1. FPNV Positioning Matrix
    14.2. Market Share Analysis, By Key Player
    14.3. Competitive Scenario Analysis, By Key Player
    15. Competitive Portfolio
    15.1. Key Company Profiles
    15.1.1. AbbVie Inc.
    15.1.2. Accord Healthcare US
    15.1.3. Akorn Operating Company LLC
    15.1.4. Alvogen
    15.1.5. Amneal Pharmaceuticals LLC
    15.1.6. Apotex Inc.
    15.1.7. AstraZeneca PLC
    15.1.8. Bausch Health Companies Inc.
    15.1.9. Dellwich Healthcare LLP
    15.1.10. Eli Lilly and Company
    15.1.11. F. Hoffmann-La Roche Ltd.
    15.1.12. GlaxoSmithKline PLC
    15.1.13. H. Lundbeck A/S
    15.1.14. Hameln Pharma GmbH
    15.1.15. Hikma Pharmaceuticals PLC
    15.1.16. Johnson & Johnson Services, Inc.
    15.1.17. Lifecare Neuro Products Limited
    15.1.18. Lifegenix
    15.1.19. Neurocon Inc.
    15.1.20. Noreva Biotech
    15.1.21. Novartis AG
    15.1.22. Pfizer Inc.
    15.1.23. Sanofi S.A.
    15.1.24. Sun Pharmaceutical Industries Ltd.
    15.2. Key Product Portfolio
    16. Appendix
    16.1. Discussion Guide
    16.2. License & Pricing
    FIGURE 1. ANXIOLYTICS MARKET RESEARCH PROCESS
    FIGURE 2. ANXIOLYTICS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ANXIOLYTICS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ANXIOLYTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ANXIOLYTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ANXIOLYTICS MARKET DYNAMICS
    FIGURE 7. ANXIOLYTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
    FIGURE 8. ANXIOLYTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ANXIOLYTICS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
    FIGURE 10. ANXIOLYTICS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
    FIGURE 12. ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. ANXIOLYTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
    FIGURE 14. ANXIOLYTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
    FIGURE 16. ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 20. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 22. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 25. ANXIOLYTICS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 26. ANXIOLYTICS MARKET SHARE, BY KEY PLAYER, 2023

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us